Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-EN
Language English English
Date Updated 2022-03-11 2022-03-10
Drug Identification Number 02243763 02243763
Brand name COMTAN COMTAN
Common or Proper name COMTAN COMTAN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ENTACAPONE ENTACAPONE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100FCT BO 100FCT BO
ATC code N04BX N04BX
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-25 2022-02-25
Estimated end date 2022-03-03 2022-03-03
Actual end date 2022-03-10 2022-03-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product discontinued Product discontinued
Health Canada comments